News

Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...
Which UNC System majors got waivers to keep DEI courses after Trump ban?
Learn more in The N&O’s higher education newsletter about the programs across the UNC System that are being allowed to ...